Clinical Trial Detail

NCT ID NCT02643667
Title A Study of Ibrutinib as Neoadjuvant Therapy in Localized Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors Lawrence Fong
Indications

prostate adenocarcinoma

Therapies

Ibrutinib

Age Groups: adult senior

No variant requirements are available.